Medicare Enrolled
Dr. Raveen Arora, M.D.
Cardiovascular Disease · Anaheim, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Arora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Arora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Arora
Dr. Raveen Arora is a cardiovascular disease specialist in Anaheim, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Arora performed 18,444 Medicare services across 6,421 unique beneficiaries.
Between the years covered by Open Payments, Dr. Arora received a total of $115,260 from 59 pharmaceutical and/or device companies across 1471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Arora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in CA
$115,260 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,444
Medicare services
Top 2% in CA for cardiovascular disease
6,421
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~922 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
2,781 | $41 | $58 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
2,417 | $34 | $47 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,082 | $68 | $155 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,995 | $106 | $285 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,811 | $35 | $47 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
1,372 | $44 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
947 | $12 | $35 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
538 | $178 | $470 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
493 | $149 | $400 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
448 | $33 | $43 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
352 | $147 | $425 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
308 | $102 | $220 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
302 | $30 | $80 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
247 | $178 | $460 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
220 | $22 | $60 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
220 | $805 | $2,140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $74 | $205 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
166 | $61 | $165 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
143 | $62 | $180 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
125 | $48 | $130 |
| New patient office visit, complex (60-74 min) | 108 | $174 | $490 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
82 | $18 | $23 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
79 | $27 | $85 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
78 | $18 | $60 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
75 | $73 | $205 |
| Annual depression screening | 75 | $21 | $45 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
74 | $72 | $200 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
71 | $144 | $295 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
70 | $34 | $40 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
67 | $75 | $135 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
63 | $65 | $150 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
63 | $244 | $620 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
61 | $10 | $116 |
| Cardiac catheterization | 56 | $220 | $625 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
52 | $182 | $456 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
39 | $18 | $140 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
27 | $250 | $640 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
24 | $45 | $120 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
22 | $32 | $190 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $122 | $370 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
16 | $178 | $455 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
15 | $3 | $10 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
15 | $31 | $175 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
15 | $98 | $285 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
14 | $7 | $20 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
12 | $461 | $1,240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.5% high complexity
2.9% medium
92.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$115,260
Total received (2018-2024)
Avg $16,466/year across 7 years
Top 6% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
1,471
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$87,084 (75.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,359 (23.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$816 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,509
2023
$5,163
2022
$4,646
2021
$4,797
2020
$9,757
2019
$24,696
2018
$56,692
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$4,637
AstraZeneca Pharmaceuticals LP
$1,012
Boehringer Ingelheim Pharmaceuticals, Inc.
$528
Novo Nordisk Inc
$378
Lilly USA, LLC
$322
Edwards Lifesciences Corporation
$301
Novartis Pharmaceuticals Corporation
$232
Bayer Healthcare Pharmaceuticals Inc.
$231
ShockWave Medical, Inc
$203
Alnylam Pharmaceuticals Inc.
$189
PFIZER INC.
$167
Abbott Laboratories
$166
Medtronic, Inc.
$165
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$152
Kiniksa Pharmaceuticals International, plc
$146
Janssen Pharmaceuticals, Inc
$107
E.R. Squibb & Sons, L.L.C.
$88
SCPHARMACEUTICALS INC.
$83
Kestra Medical Technology Services, Inc.
$81
Merck Sharp & Dohme LLC
$70
SANOFI-AVENTIS U.S. LLC
$58
Esperion Therapeutics, Inc.
$40
Azurity Pharmaceuticals, Inc.
$38
United Therapeutics Corporation
$30
Lundbeck LLC
$24
Sumitomo Pharma America, Inc.
$24
Tactile Systems Technology Inc
$19
Lexicon Pharmaceuticals, Inc.
$16
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amarin Pharma Inc.
$54,783
Kowa Pharmaceuticals America, Inc.
$16,432
Novartis Pharmaceuticals Corporation
$11,075
Amgen Inc.
$7,237
Medicure Pharma Inc.
$3,298
AstraZeneca Pharmaceuticals LP
$2,034
Novo Nordisk Inc
$1,905
Janssen Pharmaceuticals, Inc
$1,534
PFIZER INC.
$1,258
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,224
E.R. Squibb & Sons, L.L.C.
$953
Alnylam Pharmaceuticals Inc.
$876
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$853
Lilly USA, LLC
$853
Bayer HealthCare Pharmaceuticals Inc.
$851
Impulse Dynamics (USA) Inc.
$835
Abbott Laboratories
$812
Esperion Therapeutics, Inc.
$784
Bayer Healthcare Pharmaceuticals Inc.
$719
Medtronic, Inc.
$630
ARBOR PHARMACEUTICALS, INC.
$620
Regeneron Healthcare Solutions, Inc.
$618
Edwards Lifesciences Corporation
$576
SANOFI-AVENTIS U.S. LLC
$483
BIOTRONIK INC.
$469
Gilead Sciences, Inc.
$376
Arbor Pharmaceuticals, Inc.
$300
Lundbeck LLC
$293
Merck Sharp & Dohme LLC
$277
Azurity Pharmaceuticals, Inc.
$257
ShockWave Medical, Inc
$203
GlaxoSmithKline, LLC.
$197
Allergan Inc.
$154
Cardiovascular Systems Inc.
$150
Kiniksa Pharmaceuticals International, plc
$146
Medtronic Vascular, Inc.
$134
Tactile Systems Technology Inc
$131
SCPHARMACEUTICALS INC.
$123
Noden Pharma USA Inc
$111
Kestra Medical Technology Services, Inc.
$108
Merck Sharp & Dohme Corporation
$105
ATRICURE, INC.
$98
Shield Therapeutics Inc
$39
SANOFI PASTEUR INC.
$37
CVRx, Inc.
$34
United Therapeutics Corporation
$30
HeartFlow, Inc.
$30
Mylan Specialty L.P.
$26
CHIESI USA, INC.
$24
Sumitomo Pharma America, Inc.
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$23
Kiniksa Pharmaceuticals, Ltd.
$20
Boston Scientific Corporation
$17
AbbVie, Inc.
$16
Lexicon Pharmaceuticals, Inc.
$16
Actelion Pharmaceuticals US, Inc.
$13
Itamar Medical Inc
$13
Daiichi Sankyo Inc.
$12
Amryt Pharma Holdings Ltd
$11
Top 3 companies account for 71.4% of all-time payments
Associated products mentioned in payments ›
25208-201-09 · ACCRUFER · ADVAIR · AIRSUPRA · AMVUTTRA · AREXVY · ATRICLIP LAA EXCLUSION SYSTEM · Acticor 7 VR-T DX · Adempas · Androgel · Arcalyst · Arctic Front · Assure WCD · BREZTRI · BRILINTA · BYDUREON · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · Corlanor · DRAGONFLY OPSTAR · Diamondback Coronary · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FLEXITOUCH · FLUZONE QUADRIVALENT · FUROSCIX · Flexitouch Plus · GEMTESA · HMG-CoA reductase inhibitor. · HORIZANT · HeartMate 3 Left Ventricular Assist Device · Horizant · INJECTAFER · Iforia 5 VR-T DX · JANUVIA · JARDIANCE · JUXTAPID · KAPSPARGO · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LINQ II · LINZESS · LOKELMA · LifeVest · Livalo · MICRA · MOUNJARO · MULTAQ · MYLOTARG · Micra · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · ONYX FRONTIER · Optimizer · Optimizer Smart System · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · REXULTI · Repatha · SHINGRIX · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TEKTURNA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TOUJEO · TRULICITY · TYVASO · UPTRAVI · VERQUVO · VIBERZI · VYNDAQEL · Vascepa · Victoza · WAINUA · WatchPAT · XARELTO · YUPELRI · ZEPBOUND · ZYPITAMAG · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
450
Per 100K population
14.2
County median income
$113,702
Nearest hospital
AHMC ANAHEIM REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Arora is a clinical cardiology specialist, with above-average Medicare volume (top 2% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Arora experienced with remote patient monitoring management, 20 min/month?
Based on Medicare claims data, Dr. Arora performed 2,781 remote patient monitoring management, 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Arora receive payments from pharmaceutical companies?
Yes. Dr. Arora received a total of $115,260 from 59 companies across 1,471 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Arora's costs compare to other cardiologists in Anaheim?
Dr. Arora's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Arora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Anaheim
Browse cardiologists in Anaheim ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Kowa Pharmaceuticals America, Inc. Payments to Doctors
See all physicians who received payments from Kowa Pharmaceuticals America, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology